Loading...
XETR
GME
Market cap16mUSD
Jul 10, Last price  
2.77EUR
Name

Geratherm Medical AG

Chart & Performance

D1W1MN
XETR:GME chart
P/E
P/S
1.01
EPS
Div Yield, %
3.66%
Shrs. gr., 5y
1.80%
Rev. gr., 5y
-11.56%
Revenues
15m
-27.22%
8,589,6138,802,00310,734,56414,914,43617,783,09718,981,11116,280,27617,029,04018,714,64121,588,89522,062,98421,030,77921,521,92019,851,17627,466,23024,638,67325,850,61920,955,85220,425,22514,864,994
Net income
-819k
L
00-2,920,6172,678,5452,542,2901,095,1151,194,1901,333,7811,682,3592,701,2652,236,805679,7871,153,595289,8572,045,328122,2351,023,4461,111,156705,172-818,985
CFO
1m
-25.76%
240,9201,038,620473,0002,710,000427,0001,063,0001,605,0002,438,000952,0003,774,000792,0002,466,0001,347,0001,540,0003,915,000917,0002,785,0001,472,0001,867,0001,386,000
Dividend
Jul 28, 20250.1 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Geratherm Medical AG, a German-based medical technology enterprise, organizes its operations across four primary divisions: Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems. The Healthcare Diagnostic unit offers a range of items including clinical thermometers, blood pressure monitors, and various self-test diagnostic products designed for women, such as pregnancy tests, chlamydia screens, urinary tract infection indicators, diverse ovulation solutions, and pH tests. Its Respiratory segment is dedicated to the development and production of equipment primarily for diagnosing pulmonary and cardiopulmonary function. Under the LMT brand, the Medical Warming Systems division manufactures MRI-compatible incubators for premature and newborn infants. The Cardio/Stroke segment provides analytical products aimed at assessing stroke risk by detecting atrial fibrillation. The company markets its healthcare solutions via pharmacies, hospitals, and clinics, and successfully exports its merchandise to approximately 60 nations worldwide. Established in 1990, Geratherm Medical AG's headquarters are situated in Geschwenda, Germany.
IPO date
Jul 03, 2000
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT